Citadel Advisors
TWST icon

Citadel Advisors’s Twist Bioscience TWST Stock Holding History

Citadel Advisors’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$88.7M Sell
862,042
-358,358
-29% -$23.3M 0.01% 1064
2026
Q1 		$58M Buy
1,220,400
+1,188,351
+3,708% +$53.3M 0.01% 1226
2025
Q4 		$1.02M Sell
32,049
-83,196
-72% -$2.6M ﹤0.01% 7362
2025
Q3 		$3.24M Sell
115,245
-1,388,301
-92% -$42M ﹤0.01% 5160
2025
Q2 		$55.3M Buy
1,503,546
+432,280
+40% +$14.9M 0.01% 1168
2025
Q1 		$42.1M Sell
1,071,266
-330,991
-24% -$14.9M 0.01% 1283
2024
Q4 		$65.2M Sell
1,402,257
-80,299
-5% -$3.63M 0.01% 1045
2024
Q3 		$67M Buy
1,482,556
+54,746
+4% +$2.6M 0.01% 980
2024
Q2 		$70.4M Sell
1,427,810
-284,635
-17% -$11.6M 0.01% 882
2024
Q1 		$58.8M Sell
1,712,445
-127,171
-7% -$4.59M 0.01% 1081
2023
Q4 		$67.8M Buy
1,839,616
+281,165
+18% +$6.5M 0.01% 954
2023
Q3 		$31.6M Sell
1,558,451
-6,276
-0.4% -$138K 0.01% 1457
2023
Q2 		$32M Buy
1,564,727
+390,899
+33% +$5.86M 0.01% 1420
2023
Q1 		$17.7M Buy
1,173,828
+608,802
+108% +$13.4M ﹤0.01% 2053
2022
Q4 		$13.5M Buy
565,026
+497,109
+732% +$14.4M ﹤0.01% 2422
2022
Q3 		$2.39M Sell
67,917
-410,309
-86% -$17.4M ﹤0.01% 5249
2022
Q2 		$16.7M Buy
478,226
+271,200
+131% +$9.61M ﹤0.01% 2037
2022
Q1 		$10.2M Buy
207,026
+21,006
+11% +$1.16M ﹤0.01% 2916
2021
Q4 		$14.4M Buy
186,020
+103,007
+124% +$10.6M ﹤0.01% 2484
2021
Q3 		$8.88M Buy
83,013
+78,595
+1,779% +$9M ﹤0.01% 3271
2021
Q2 		$589K Buy
4,418
+480
+12% +$55.8K ﹤0.01% 9666
2021
Q1 		$488K Sell
3,938
-343
-8% -$52.1K ﹤0.01% 9727
2020
Q4 		$605K Sell
4,281
-12,283
-74% -$1.36M ﹤0.01% 7800
2020
Q3 		$1.26M Sell
16,564
-41,296
-71% -$2.57M ﹤0.01% 5610
2020
Q2 		$2.62M Buy
+57,860
New +$2.08M ﹤0.01% 4099
2020
Q1 		– Sell
-146,802
Closed -$3.08M – 10202
2019
Q4 		$3.08M Buy
146,802
+55,525
+61% +$1.3M ﹤0.01% 3745
2019
Q3 		$2.18M Buy
+91,277
New +$2.65M ﹤0.01% 4348

Other funds holding TWST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Citadel Advisors's TWST Position: Q2 2026 in Review

Citadel Advisors reduced its Twist Bioscience (TWST) stake by 29% in Q2 2026, selling an estimated $23.3M and leaving 862,042 shares worth $88.7M. The position accounts for 0.01% of the portfolio, ranked #1064.

Citadel Advisors first reported a position in TWST in Q3 2019 and has held it in 27 quarters since. 338 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • Citadel Advisors held 862,042 shares of Twist Bioscience worth $88.7M as of Q2 2026.
  • Citadel Advisors sold 358,358 Twist Bioscience shares in Q2 2026, an estimated $23.3M.
  • Twist Bioscience made up 0.01% of Citadel Advisors's portfolio in Q2 2026, its #1064 holding.
  • Citadel Advisors first reported a position in Twist Bioscience in Q3 2019 and has held it in 27 quarters since.
  • 338 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.